Talis Biomedical Corporation (TLIS)

USD 1.6

(6.67%)

Revenue Summary of Talis Biomedical Corporation

  • Talis Biomedical Corporation's latest annual revenue in 2023 was 412 Thousand USD , down -88.72% from previous year.
  • Talis Biomedical Corporation's latest quarterly revenue in 2024 Q2 was - USD , down -100.0% from previous quarter.
  • Talis Biomedical Corporation reported a annual revenue of 3.65 Million USD in annual revenue 2022, down 0.0% from previous year.
  • Talis Biomedical Corporation reported a annual revenue of - USD in annual revenue 2021, down -100.0% from previous year.
  • Talis Biomedical Corporation reported a quarterly revenue of - USD for 2024 Q2, down -100.0% from previous quarter.
  • Talis Biomedical Corporation reported a quarterly revenue of 151 Thousand USD for 2023 Q4, up 98.68% from previous quarter.

Annual Revenue Chart of Talis Biomedical Corporation (2023 - 2018)

Historical Annual Revenue of Talis Biomedical Corporation (2023 - 2018)

Year Revenue Revenue Growth
2023 412 Thousand USD -88.72%
2022 3.65 Million USD 0.0%
2021 - USD -100.0%
2020 10.93 Million USD 175.03%
2019 3.97 Million USD 66.4%
2018 2.39 Million USD 0.0%

Peer Revenue Comparison of Talis Biomedical Corporation

Name Revenue Revenue Difference
Acutus Medical, Inc. 7.16 Million USD 94.249%
Biotricity, Inc. 12.06 Million USD 96.585%
Cell MedX Corp. - USD -Infinity%
Dynatronics Corporation 32.53 Million USD 98.734%
Nemaura Medical Inc. 77.04 Thousand USD -434.759%
PetVivo Holdings, Inc. 968.7 Thousand USD 57.469%
RetinalGenix Technologies Inc. - USD -Infinity%
Sonendo, Inc. 43.86 Million USD 99.061%
Telesis Bio, Inc. 27.5 Million USD 98.502%
Viveve Medical, Inc. 6.42 Million USD 93.589%